Dysautonomia in anti-Hu paraneoplastic neurological syndromes

被引:1
|
作者
Villagran-Garcia, Macarena [1 ,2 ]
Farina, Antonio [1 ,2 ,3 ]
Arzalluz-Luque, Joaquin [1 ,4 ]
Campetella, Lucia [1 ]
Muniz-Castrillo, Sergio [1 ,5 ]
Benaiteau, Marie [1 ]
Peter, Elise [1 ,2 ]
Dumez, Pauline [1 ,2 ]
Wucher, Valentin [1 ,2 ]
Dhairi, Maroua [1 ]
Picard, Geraldine [1 ]
Rafiq, Marie [6 ]
Psimaras, Dimitri [7 ,8 ]
Rogemond, Veronique [1 ,2 ]
Joubert, Bastien [1 ,2 ]
Honnorat, Jerome [1 ,2 ]
机构
[1] Hosp Civils Lyon, Hop Neurol, French Reference Ctr Paraneoplast Neurol Syndromes, 59 Bd Pinel, F-69677 Bron, France
[2] Univ Claude Bernard Lyon 1, CNRS UMR 5284, UCBL,U1314, INSERM,MeLiS, F-69008 Lyon, France
[3] Univ Florence, Dept Neurosci Psychol Pharmacol & Child Hlth, I-50139 Florence, Italy
[4] Hosp Univ Virgen Macarena, Dept Neurol, Seville 41009, Spain
[5] Stanford Univ, Ctr Sleep Sci & Med, Palo Alto, CA 94304 USA
[6] Univ Hosp Toulouse, Dept Neurol, F-31300 Toulouse, France
[7] Hosp Grp Pitie Salpetriere, AP HP, Neurol Dept Mazarin 2, F-75013 Paris, France
[8] Paris Brain Inst, Inst Cerveau & Moelle Epiniere ICM, Inserm, CNRS, F-75013 Paris, France
关键词
Dysautonomia; Autonomic function; Paraneoplastic autoimmunity; Hu; ANNA-1; POSITIVE PATIENTS; ENCEPHALOMYELITIS; TUMOR;
D O I
10.1007/s00415-024-12278-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and objectives Dysautonomia has been associated with paraneoplastic neurological syndrome (PNS)-related mortality in anti-Hu PNS, but its frequency and spectrum remain ill-defined. We describe anti-Hu patients with dysautonomia, estimate its frequency, and compare them to patients without dysautonomia. Methods Patients with anti-Hu antibodies diagnosed in the study centre (1990-2022) were retrospectively reviewed; those with autonomic signs and symptoms were identified. Results Among 477 anti-Hu patients, 126 (26%) had dysautonomia (the only PNS manifestation in 7/126, 6%); gastrointestinal (82/126, 65%), cardiovascular (64/126, 51%), urogenital (24/126, 19%), pupillomotor/secretomotor (each, 11/126, 9%), and central hypoventilation (10/126, 8%). Patients with isolated CNS involvement less frequently had gastrointestinal dysautonomia than those with peripheral (alone or combined with CNS) involvement (7/23, 30% vs. 31/44, 70% vs. 37/52, 71%; P = 0.002); while more frequently central hypoventilation (7/23, 30% vs. 1/44, 2.3% vs. 2/52, 4%; P < 0.001) and/or cardiovascular alterations (18/23, 78% vs. 20/44, 45% vs. 26/52, 50%; P = 0.055). Median [95% CI] overall survival was not significantly different between patients with (37 [17; 91] months) or without dysautonomia (28 [22; 39] months; P = 0.78). Cardiovascular dysautonomia (HR: 1.57, 95% CI [1.05; 2.36]; P = 0.030) and central hypoventilation (HR: 3.51, 95% CI [1.54; 8.01]; P = 0.003) were associated with a higher risk of death, and secretomotor dysautonomia a lower risk (HR: 0.28, 95% CI [0.09; 0.89]; P = 0.032). Patients with cardiovascular dysautonomia dying <= 1 year from clinical onset had severe CNS (21/27, 78%), frequently brainstem (13/27, 48%), involvement. Discussion Anti-Hu PNS dysautonomia is rarely isolated, frequently gastrointestinal, cardiovascular and urogenital. CNS dysfunction, particularly brainstem, associates with lethal cardiovascular alterations and central hypoventilation, while peripheral involvement preferentially associates with gastrointestinal or secretomotor dysautonomia, being the latest more indolent.
引用
收藏
页码:3359 / 3369
页数:11
相关论文
共 50 条
  • [41] Orolingual tremor as unusual presentation of anti-Hu paraneoplastic syndrome
    Valentino, Paola
    Labate, Angelo
    Pirritano, Domenico
    Crescibene, Lucia
    Cascini, Giuseppe
    Quattrone, Aldo
    MOVEMENT DISORDERS, 2008, 23 (12) : 1791 - 1792
  • [42] Facial pain as first manifestation of anti-Hu paraneoplastic syndrome
    Geneviève Demarquay
    Adrien Didelot
    Véronique Rogemond
    Philippe Ryvlin
    Michel Gouttard
    Paul Garassus
    François Mauguière
    Jérome Honnorat
    The Journal of Headache and Pain, 2010, 11 : 355 - 357
  • [43] Human chorionic gonadotropin treatment of anti-Hu-associated paraneoplastic neurological syndromes
    van Broekhoven, F.
    de Graaf, M. T.
    Bromberg, J. E.
    Hooijkaas, H.
    van den Bent, M. J.
    de Beukelaar, J. W.
    Khan, N. A.
    Gratama, J. W.
    van der Geest, J. N.
    Frens, M.
    Benner, R.
    Smitt, P. A. Sillevis
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (12): : 1341 - 1344
  • [44] 'ANTI-HU SYNDROME' - A CASE OF PARANEOPLASTIC SENSORY NEUROPATHY WITH ENCEPHALITIS
    Srishti, Gupta
    Amit, Jaiswal
    Michael, Knopp
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (10):
  • [45] Case report: Paraneoplastic anti-Hu seropositive spinal atrophy
    Arnaoutoglou, M.
    Koutsouraki, E.
    Kosta, V.
    Kapsali, S. A.
    Andreopoulou, G.
    Spanos, G.
    Tihalas, A.
    Arnaoutoglou, A.
    Baloyannis, S. J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 104 - 104
  • [46] Thymoma associated with myasthenia and autonomic anti-Hu paraneoplastic neuropathy
    Simonelli, Matteo
    Banna, Giuseppe Luigi
    Santoro, Armando
    TUMORI, 2009, 95 (02) : 243 - 247
  • [47] Dysphagia and constipation as clinical manifestations of anti-Hu paraneoplastic syndrome
    Guardiola, H
    Vilaseca, B
    Martí, S
    de la Torre, N
    MEDICINA CLINICA, 2004, 123 (10): : 398 - 399
  • [48] PARANEOPLASTIC OPSOCLONUS-MYOCLONUS ASSOCIATED WITH ANTI-HU ANTIBODY
    HERSH, B
    DALMAU, J
    DANGOND, F
    GULTEKIN, S
    GELLER, E
    WEN, PY
    NEUROLOGY, 1994, 44 (09) : 1754 - 1755
  • [49] Worsening of Anti-Hu Paraneoplastic Neurological Syndrome related to Anti-PD- Treatment: Case Report and Literature Review
    Raibagkar, Pooja
    Ho, Doreen
    Gunturu, Krishna
    Srinivasan, Jayashri
    NEUROLOGY, 2020, 94 (15)
  • [50] Spontaneous neurological improvement in anti-Hu associated encephalomyelitis
    Byrne, T
    Mason, WP
    Posner, JB
    Dalmau, J
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 62 (03): : 276 - 278